If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Option Care ...

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...

Option Care gets 75% of its revenues from chronic therapies and 25% from acute treatments, but its growth now looks ...

Jefferies analyst Brian Tanquilut upgraded the rating on Option Care Health (OPCH – Research Report) to a Buy today, setting a price target of ...

BANNOCKBURN, Ill., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest ...

Option Care Health announces preliminary financial results for Q4 and full year 2024, expecting significant revenue growth and new share repurchase program. Option Care Health, Inc. announced ...

Jefferies has upgraded Option Care Health (NASDAQ:OPCH) to buy from hold, citing removal of an overhang related to pricing adjustments for the drug Stelara. The investment bank said it had ...

JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and keeps an Outperform ...

Ratings for Option Care Health (NASDAQ:OPCH) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments ...

In this article, we are going to take a look at where Option Care Health (NASDAQ:OPCH) stands against the other stocks. Stock gains always get people talking, and 2025 is no exception. Markets ...